| ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
DUSP10 |
DUSP10, MKP5: Dual specificity protein phosphatase 10 |
2.43 |
Evidence |
|
| PAX7 |
PAX7, HUP1: Paired box protein Pax-7 |
AHR |
AHR: Aryl hydrocarbon receptor precursor |
2.43 |
Evidence |
|
| MMP8 |
CLG1, MMP8: Neutrophil collagenase precursor |
C21orf29 |
TSPEAR, C21orf29: Protein TSPEAR precursor |
2.43 |
Evidence |
|
| MMP8 |
CLG1, MMP8: Neutrophil collagenase precursor |
CEACAM7 |
CEACAM7, CGM2: Carcinoembryonic antigen-related cell adhesion molecule 7 precurs |
2.43 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
ASB17 |
ASB17: Ankyrin repeat and SOCS box protein 17 |
2.43 |
Evidence |
|
| VDAC1 |
VDAC1, VDAC: Voltage-dependent anion-selective channel protein 1 |
BAX |
BAX: Apoptosis regulator BAX, cytoplasmic isoform beta |
2.43 |
Evidence |
|
| TBXA2R |
TBXA2R: Thromboxane A2 receptor |
HTR2B |
HTR2B: 5-hydroxytryptamine receptor 2B |
2.43 |
Evidence |
|
| TBXA2R |
TBXA2R: Thromboxane A2 receptor |
ADORA1 |
ADORA1: Adenosine receptor A1 |
2.43 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
BRDG1 |
STAP1, BRDG1: Signal-transducing adaptor protein 1 |
2.43 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
GRB7 |
GRB7: Growth factor receptor-bound protein 7 |
2.43 |
Evidence |
|
| TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
TNFRSF25 |
TNFRSF25, APO3, UNQ455/PRO779, DDR3, DR3, TNFRSF12, WSL, WSL1: Tumor necrosis fa |
2.43 |
Evidence |
|
| TFEB |
TFEB: Transcription factor EB |
PAX2 |
PAX2: Paired box protein Pax-2 |
2.43 |
Evidence |
|
| CDH2 |
CDH2, CDHN, NCAD: Cadherin-2 precursor |
PCDHGA9 |
PCDHGA9: Protocadherin gamma A9 precursor |
2.43 |
Evidence |
|
| CDH2 |
CDH2, CDHN, NCAD: Cadherin-2 precursor |
PCDHA4 |
PCDHA4: Protocadherin alpha 4 precursor |
2.43 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
WSB1 |
WSB1, SWIP1: WD repeat and SOCS box-containing protein 1 |
2.43 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
WHSC1 |
IPI00107486 |
2.43 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
BRDG1 |
STAP1, BRDG1: Signal-transducing adaptor protein 1 |
2.43 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
CISH |
CISH, G18: Cytokine-inducible SH2-containing protein |
2.43 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
PLEKHA4 |
PLEKHA4, PEPP1: Pleckstrin homology domain-containing family A member 4 |
2.43 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
DOK6 |
DOK6: Uncharacterized protein DOK6 |
2.43 |
Evidence |
|
| NID1 |
NID1, NID: Nidogen-1 precursor |
ADAMTS10 |
ADAMTS10: ADAMTS-10 precursor |
2.43 |
Evidence |
|
| NID1 |
NID1, NID: Nidogen-1 precursor |
SERPINA11 |
SERPINA11: Serpin A11 precursor |
2.43 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
ADORA1 |
ADORA1: Adenosine receptor A1 |
2.43 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
FGF21 |
FGF21, UNQ3115/PRO10196: Fibroblast growth factor 21 precursor |
2.43 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
IL24 |
IL24, MDA7, ST16: Interleukin-24 precursor |
2.43 |
Evidence |
|